News Focus
News Focus
icon url

KILLAZILLA

12/11/20 12:25 PM

#1835 RE: MomsSpaghetti #1832

Savant bought 18-MC, we bought savant with 18-MC. Glick is on our board. They (savant) got a grant for trials but ran out of funding. Stephen Hurst the real CEO was owner of savant. Can't remember off top of my head how much the paid him or how many shares he got but it was a good amount.

Nothing much to discuss other than the drug works or it doesn't. That's what trials are for.
icon url

mick

12/11/20 12:55 PM

#1838 RE: MomsSpaghetti #1832

Mind Medicine MindMe (MMEDF)
3.37 ? 0.52 (18.25%)
Volume: 10,249,450 @12/11/20 12:39:50 PM EST
Bid Ask Day's Range
3.36 3.38 2.81 - 3.5
MMEDF Detailed Quote
icon url

KILLAZILLA

12/11/20 1:04 PM

#1839 RE: MomsSpaghetti #1832

MindMed has to send the lawyers and patent police knocking on their doors.

"They engineered a new, synthetic molecule which they named tabernanthalog or TBG."
Thieves